However, we did not observe increased OX40 expression after CpG+RT (Supplemental Figure 6B), nor did we observe a synergistic treatment effect with anti-OX40 in the p53/MCA sarcoma model (Supplemental Figure 6A). This evidence concerns the gene TNFRSF4 and sarcoma.